Munich, Germany

Robert Saller


Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • München, DE (2002 - 2011)
  • Munich, DE (2006 - 2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Saller

Introduction

Robert Saller is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of metastatic breast cancer. With a total of 10 patents to his name, Saller's work has the potential to impact many lives.

Latest Patents

Among his latest patents, Saller has developed a method involving the use of an anti-EpCAM antibody for the manufacture of a medicament aimed at treating metastatic breast cancer. This invention not only highlights his innovative approach but also emphasizes the importance of targeted therapies in modern medicine. The method of treating metastatic breast cancer involves administering the anti-EpCAM antibody, showcasing Saller's commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Robert Saller has worked with prominent organizations, including Amgen Research GmbH in Munich. His experience in such a reputable company has allowed him to refine his skills and contribute to groundbreaking research in the medical field.

Collaborations

Saller has collaborated with several professionals in his field, including Brian Salmons and Carsten Reinhardt. These collaborations have likely enriched his research and led to innovative solutions in cancer treatment.

Conclusion

Robert Saller's contributions to the field of medical research, particularly in the treatment of metastatic breast cancer, demonstrate his dedication to innovation. His patents and collaborations reflect a commitment to improving patient outcomes through advanced therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…